当前位置:首页 - 行情中心 - 贝瑞基因(000710) - 财务分析 - 现金流量表

贝瑞基因

(000710)

  

流通市值:30.90亿  总市值:32.56亿
流通股本:3.36亿   总股本:3.54亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金684,394,317.48441,228,846.38204,932,500.091,064,649,230.75
  收到的税费返还182,362.31182,362.31177,278.853,345,900.07
  收到其他与经营活动有关的现金3,785,532.662,319,694.981,612,923.4427,480,795.41
  经营活动现金流入小计688,362,212.45443,730,903.67206,722,702.381,095,475,926.23
  购买商品、接受劳务支付的现金435,151,752.97293,548,897.19175,435,173.56513,576,328.14
  支付给职工以及为职工支付的现金229,813,132.29156,401,698.9576,841,487.36319,962,324.55
  支付的各项税费37,482,813.7425,767,358.357,945,156.3149,833,795.32
  支付其他与经营活动有关的现金119,390,567.7270,272,134.5338,133,334.74141,495,745.53
  经营活动现金流出小计821,838,266.72545,990,089.02298,355,151.971,024,868,193.54
  经营活动产生的现金流量净额-133,476,054.27-102,259,185.35-91,632,449.5970,607,732.69
二、投资活动产生的现金流量:
  收回投资收到的现金---9,934,868.38
  处置固定资产、无形资产和其他长期资产收回的现金净额6,170,229.856,126,047.856,108,047.8512,066,680
  投资活动现金流入小计6,170,229.856,126,047.856,108,047.8522,001,548.38
  购建固定资产、无形资产和其他长期资产支付的现金36,123,730.2625,589,719.6713,395,755.9575,683,852.1
  投资支付的现金6,354,056.226,354,056.226,354,056.2212,062,498.07
  投资活动现金流出小计42,477,786.4831,943,775.8919,749,812.1787,746,350.17
  投资活动产生的现金流量净额-36,307,556.63-25,817,728.04-13,641,764.32-65,744,801.79
三、筹资活动产生的现金流量:
  吸收投资收到的现金--30,000,0001,600,000
  其中:子公司吸收少数股东投资收到的现金---1,600,000
  取得借款收到的现金274,048,868.9116,048,868.9106,048,868.9182,848,975.65
  收到其他与筹资活动有关的现金39,000,00039,000,0009,000,000-
  筹资活动现金流入小计313,048,868.9155,048,868.9145,048,868.9184,448,975.65
  偿还债务支付的现金280,218,528.9151,669,660105,240,917.78141,975,571.33
  分配股利、利润或偿付利息支付的现金3,403,311.612,478,489.741,227,568.344,728,898.78
  支付其他与筹资活动有关的现金39,196,056.6818,499,196.649,000,00025,688,064.98
  筹资活动现金流出小计322,817,897.19172,647,346.38115,468,486.12172,392,535.09
  筹资活动产生的现金流量净额-9,769,028.29-17,598,477.4829,580,382.7812,056,440.56
四、汇率变动对现金及现金等价物的影响-5,287,526.38-3,349,260.9-2,225,966.99-3,027,599.87
五、现金及现金等价物净增加额-184,840,165.57-149,024,651.77-77,919,798.1213,891,771.59
  加:期初现金及现金等价物余额372,204,585.73372,204,585.73372,204,585.73358,312,814.14
  期末现金及现金等价物余额187,364,420.16223,179,933.96294,284,787.61372,204,585.73
补充资料:
  净利润--43,116,696.55--196,294,138.02
  资产减值准备----674,124.35
  固定资产和投资性房地产折旧-28,607,172.1-59,359,691.09
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-28,607,172.1-59,359,691.09
  无形资产摊销-4,040,321.53-4,651,985.12
  长期待摊费用摊销-7,356,383.31-13,596,012.38
  处置固定资产、无形资产和其他长期资产的损失-1,884,589.29--4,998,568.37
  固定资产报废损失--3,266.9-247,351.76
  公允价值变动损失---2,841,154.08
  财务费用-1,757,318.99-9,405,782.45
  投资损失-645,647.25-3,537,842.81
  递延所得税-1,279,849.7--5,320,026.57
  其中:递延所得税资产减少-2,193,955.01--6,347,290.87
    递延所得税负债增加--914,105.31-1,027,264.3
  存货的减少-465,400.04-18,825,960.62
  经营性应收项目的减少--51,233,178.89-63,204,184.84
  经营性应付项目的增加--84,381,278.2--29,678,540.96
  其他----2,099,963.83
  现金的期末余额-223,179,933.96-372,204,585.73
  减:现金的期初余额-372,204,585.73-358,312,814.14
  现金及现金等价物的净增加额--149,024,651.77-13,891,771.59
公告日期2026-10-272026-08-242026-04-302026-04-29
审计意见(境内)标准无保留意见
TOP↑